CO15 Real-World Treatment Usage of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Patients in Belgium: Results of the AREVEDECY Study
Abstract
Authors
J Morrens T Lettens B Gillon M De Bevere L Poedts